Come up with a name for your new list and we'll add to it:
Interface Biologics raised a round of funding on December 06, 2011. Investors include
MaRS Investment Accelerator Fund.
Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI's primary te…